Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferrarotto R, Mitani Y, Diao L, Guijarro I, et al. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol 2017;35:352-360.
PMID: 27870570

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016